Rep. Julie Johnson Unloads Danaher Corporation (NYSE:DHR) Shares

Representative Julie Johnson (D-Texas) recently sold shares of Danaher Corporation (NYSE:DHR). In a filing disclosed on December 11th, the Representative disclosed that they had sold between $1,001 and $15,000 in Danaher stock on November 13th. The trade occurred in the Representative’s “CHASE BROKERAGE ACCOUNT (3935)” account.

Representative Julie Johnson also recently made the following trade(s):

• Sold $1,001 – $15,000 in shares of Charles Schwab (NYSE:SCHW) on 11/13/2025.
• Sold $1,001 – $15,000 in shares of UnitedHealth Group (NYSE:UNH) on 11/13/2025.
• Sold $1,001 – $15,000 in shares of Cigna Group (NYSE:CI) on 11/13/2025.
• Sold $1,001 – $15,000 in shares of Xcel Energy (NASDAQ:XEL) on 11/13/2025.
• Sold $1,001 – $15,000 in shares of Capital One Financial (NYSE:COF) on 11/13/2025.
• Sold $1,001 – $15,000 in shares of Walmart (NASDAQ:WMT) on 11/13/2025.
• Sold $1,001 – $15,000 in shares of Seagate Technology (NASDAQ:STX) on 11/13/2025.
• Sold $1,001 – $15,000 in shares of Wells Fargo & Company (NYSE:WFC) on 11/13/2025.
• Sold $1,001 – $15,000 in shares of Texas Instruments (NASDAQ:TXN) on 11/13/2025.
• Sold $1,001 – $15,000 in shares of The Goldman Sachs Group (NYSE:GS) on 11/13/2025.

Danaher Trading Up 0.8%

DHR stock traded up $1.80 during midday trading on Thursday, reaching $224.43. 3,501,819 shares of the company traded hands, compared to its average volume of 3,527,117. The firm has a market capitalization of $158.53 billion, a price-to-earnings ratio of 46.28, a P/E/G ratio of 4.32 and a beta of 0.89. Danaher Corporation has a 52-week low of $171.00 and a 52-week high of $258.23. The business has a 50 day moving average of $219.93 and a 200-day moving average of $206.66. The company has a debt-to-equity ratio of 0.33, a quick ratio of 1.10 and a current ratio of 1.52.

Danaher (NYSE:DHR) last announced its earnings results on Monday, October 20th. The conglomerate reported $1.89 EPS for the quarter, topping analysts’ consensus estimates of $1.72 by $0.17. Danaher had a return on equity of 10.92% and a net margin of 14.44%.The firm had revenue of $6.05 billion during the quarter, compared to analysts’ expectations of $6 billion. During the same quarter in the previous year, the business earned $1.71 EPS. The company’s quarterly revenue was up 4.4% on a year-over-year basis. As a group, sell-side analysts expect that Danaher Corporation will post 7.63 earnings per share for the current fiscal year.

Danaher Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, January 30th. Shareholders of record on Friday, December 26th will be given a dividend of $0.32 per share. The ex-dividend date is Friday, December 26th. This represents a $1.28 dividend on an annualized basis and a yield of 0.6%. Danaher’s dividend payout ratio is 26.39%.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently added to or reduced their stakes in the business. JPL Wealth Management LLC acquired a new position in shares of Danaher in the 3rd quarter valued at about $25,000. WFA of San Diego LLC acquired a new stake in shares of Danaher in the second quarter valued at about $26,000. Howard Hughes Medical Institute purchased a new stake in Danaher during the 2nd quarter worth approximately $27,000. ANTIPODES PARTNERS Ltd purchased a new stake in shares of Danaher during the third quarter worth approximately $27,000. Finally, TruNorth Capital Management LLC purchased a new stake in shares of Danaher during the third quarter worth $28,000. 79.05% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

A number of research firms have weighed in on DHR. Redburn Partners set a $220.00 price objective on shares of Danaher in a research report on Wednesday, October 8th. Wells Fargo & Company raised their price objective on Danaher from $230.00 to $240.00 and gave the stock an “equal weight” rating in a report on Monday. The Goldman Sachs Group assumed coverage on shares of Danaher in a report on Tuesday, December 9th. They issued a “buy” rating and a $265.00 price target for the company. HSBC upped their price objective on Danaher from $255.00 to $270.00 and gave the stock a “buy” rating in a research note on Monday, December 1st. Finally, Cowen reissued a “buy” rating on shares of Danaher in a research report on Wednesday, October 22nd. Twenty-one research analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the company’s stock. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $248.25.

Insider Activity at Danaher

In related news, Director Teri List sold 3,298 shares of Danaher stock in a transaction that occurred on Tuesday, November 18th. The stock was sold at an average price of $226.50, for a total transaction of $746,997.00. Following the transaction, the director owned 20,762 shares in the company, valued at approximately $4,702,593. This trade represents a 13.71% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, SVP Brian W. Ellis sold 21,776 shares of Danaher stock in a transaction on Wednesday, November 12th. The stock was sold at an average price of $219.23, for a total value of $4,773,952.48. Following the transaction, the senior vice president owned 14,553 shares in the company, valued at approximately $3,190,454.19. This represents a 59.94% decrease in their position. The disclosure for this sale is available in the SEC filing. Over the last 90 days, insiders sold 30,248 shares of company stock valued at $6,609,663. 11.10% of the stock is currently owned by insiders.

About Representative Johnson

Julie Johnson (Democratic Party) is a member of the U.S. House, representing Texas’ 32nd Congressional District. She assumed office on January 3, 2025. Her current term ends on January 3, 2027.

Johnson (Democratic Party) ran for election to the U.S. House to represent Texas’ 32nd Congressional District. She won in the general election on November 5, 2024.

Julie Johnson earned a B.A. in history and government from the University of Texas at Austin in 1987 and a J.D. from the University of Houston Law Center in 1991. Johnson’s career experience includes working as an attorney.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.